These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Differential modulatory effects of GSK-3β and HDM2 on sorafenib-induced AIF nuclear translocation (programmed necrosis) in melanoma. Liu Q; Mier JW; Panka DJ Mol Cancer; 2011 Sep; 10():115. PubMed ID: 21929745 [TBL] [Abstract][Full Text] [Related]
3. [Sorafenib induces apoptosis of U937 cells via inhibiting WNT signal pathway]. Xiao RZ; Chen Y; Wang LL; Ruan XX; He CM; Xiong MJ; Lin DJ Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Apr; 19(2):353-7. PubMed ID: 21518487 [TBL] [Abstract][Full Text] [Related]
4. The Raf inhibitor BAY 43-9006 (Sorafenib) induces caspase-independent apoptosis in melanoma cells. Panka DJ; Wang W; Atkins MB; Mier JW Cancer Res; 2006 Feb; 66(3):1611-9. PubMed ID: 16452220 [TBL] [Abstract][Full Text] [Related]
5. The multikinase inhibitor sorafenib potentiates TRAIL lethality in human leukemia cells in association with Mcl-1 and cFLIPL down-regulation. Rosato RR; Almenara JA; Coe S; Grant S Cancer Res; 2007 Oct; 67(19):9490-500. PubMed ID: 17909059 [TBL] [Abstract][Full Text] [Related]
7. The kinase inhibitor sorafenib induces cell death through a process involving induction of endoplasmic reticulum stress. Rahmani M; Davis EM; Crabtree TR; Habibi JR; Nguyen TK; Dent P; Grant S Mol Cell Biol; 2007 Aug; 27(15):5499-513. PubMed ID: 17548474 [TBL] [Abstract][Full Text] [Related]
8. The multikinase inhibitor sorafenib induces caspase-dependent apoptosis in PC-3 prostate cancer cells. Huang R; Chen XQ; Huang Y; Chen N; Zeng H Asian J Androl; 2010 Jul; 12(4):527-34. PubMed ID: 20473320 [TBL] [Abstract][Full Text] [Related]
9. Sorafenib, a multikinase inhibitor, enhances the response of melanoma to regional chemotherapy. Augustine CK; Toshimitsu H; Jung SH; Zipfel PA; Yoo JS; Yoshimoto Y; Selim MA; Burchette J; Beasley GM; McMahon N; Padussis J; Pruitt SK; Ali-Osman F; Tyler DS Mol Cancer Ther; 2010 Jul; 9(7):2090-101. PubMed ID: 20571072 [TBL] [Abstract][Full Text] [Related]
11. The multikinase inhibitor sorafenib induces apoptosis in highly imatinib mesylate-resistant bcr/abl+ human leukemia cells in association with signal transducer and activator of transcription 5 inhibition and myeloid cell leukemia-1 down-regulation. Rahmani M; Nguyen TK; Dent P; Grant S Mol Pharmacol; 2007 Sep; 72(3):788-95. PubMed ID: 17595328 [TBL] [Abstract][Full Text] [Related]
12. Fluvastatin enhances sorafenib cytotoxicity in melanoma cells via modulation of AKT and JNK signaling pathways. Zhang S; Doudican NA; Quay E; Orlow SJ Anticancer Res; 2011 Oct; 31(10):3259-65. PubMed ID: 21965734 [TBL] [Abstract][Full Text] [Related]
13. Combined inhibition of MAPK and mTOR signaling inhibits growth, induces cell death, and abrogates invasive growth of melanoma cells. Lasithiotakis KG; Sinnberg TW; Schittek B; Flaherty KT; Kulms D; Maczey E; Garbe C; Meier FE J Invest Dermatol; 2008 Aug; 128(8):2013-23. PubMed ID: 18323781 [TBL] [Abstract][Full Text] [Related]
14. Pharmacologic modulation of glycogen synthase kinase-3beta promotes p53-dependent apoptosis through a direct Bax-mediated mitochondrial pathway in colorectal cancer cells. Tan J; Zhuang L; Leong HS; Iyer NG; Liu ET; Yu Q Cancer Res; 2005 Oct; 65(19):9012-20. PubMed ID: 16204075 [TBL] [Abstract][Full Text] [Related]
15. Cytotoxic synergy between the multikinase inhibitor sorafenib and the proteasome inhibitor bortezomib in vitro: induction of apoptosis through Akt and c-Jun NH2-terminal kinase pathways. Yu C; Friday BB; Lai JP; Yang L; Sarkaria J; Kay NE; Carter CA; Roberts LR; Kaufmann SH; Adjei AA Mol Cancer Ther; 2006 Sep; 5(9):2378-87. PubMed ID: 16985072 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of glycogen synthase kinase-3 beta induces apoptosis and mitotic catastrophe by disrupting centrosome regulation in cancer cells. Yoshino Y; Ishioka C Sci Rep; 2015 Aug; 5():13249. PubMed ID: 26292722 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of GSK-3beta ameliorates hepatic ischemia-reperfusion injury through GSK-3beta/beta-catenin signaling pathway in mice. Xia YX; Lu L; Wu ZS; Pu LY; Sun BC; Wang XH Hepatobiliary Pancreat Dis Int; 2012 Jun; 11(3):278-84. PubMed ID: 22672822 [TBL] [Abstract][Full Text] [Related]
18. Synergistic interactions between vorinostat and sorafenib in chronic myelogenous leukemia cells involve Mcl-1 and p21CIP1 down-regulation. Dasmahapatra G; Yerram N; Dai Y; Dent P; Grant S Clin Cancer Res; 2007 Jul; 13(14):4280-90. PubMed ID: 17634558 [TBL] [Abstract][Full Text] [Related]
19. Nelfinavir induces mitochondria protection by ERK1/2-mediated mcl-1 stabilization that can be overcome by sorafenib. Brüning A; Burger P; Vogel M; Gingelmaier A; Friese K; Burges A Invest New Drugs; 2010 Oct; 28(5):535-42. PubMed ID: 19554262 [TBL] [Abstract][Full Text] [Related]
20. Glycogen synthase kinase-3beta phosphorylates Bax and promotes its mitochondrial localization during neuronal apoptosis. Linseman DA; Butts BD; Precht TA; Phelps RA; Le SS; Laessig TA; Bouchard RJ; Florez-McClure ML; Heidenreich KA J Neurosci; 2004 Nov; 24(44):9993-10002. PubMed ID: 15525785 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]